Is a complete BCBA/AZND research report available?

No complete published report is available for bcba/AZND (BCBA/AZND) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/AZND (BCBA/AZND)

Buenos Aires Stock Exchange: BCBA/AZND · USD

$45.4

-0.39 (-0.8%)· Recorded snapshot

Market cap	406.6T
Revenue (ttm)	90.9T
Net income (ttm)	15.5T
EPS (ttm)	$2,729
P/E (trailing)	25.6x
P/E (forward)	15.8x
Dividend	$1,075 (1.54%)
Volume	4

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 90.9T
Net income (ttm): 15.5T
EPS (ttm): $2,729
P/E (trailing): 25.6x
P/E (forward): 15.8x
Market cap: 406.6T

Metric	Value
Amount currency	ARS
Country	United Kingdom
Country code	AR
Earnings date	2026-10-30
Employees	96,100
Employees change	1,800
Employees growth	1.91%
Enterprise value	$449T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-18
Fiscal year end	December
Founded	1992
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT112489
Last earnings date	2026-07-27
Last refreshed	2026-10-28
Market cap	$406.6T
Next earnings date	2026-10-30
Price	$45.42
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bcba/AZND
Website	https://www.astrazeneca.com

Metric

Value

Amount currency

ARS

Country

United Kingdom

Country code

Earnings date

2026-10-30

Employees

96,100

Employees change

1,800

Employees growth

1.91%

Enterprise value

$449T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-07-18

Fiscal year end

December

Founded

1992

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARDEUT112489

Last earnings date

2026-07-27

Last refreshed

2026-10-28

Market cap

$406.6T

Next earnings date

2026-10-30

Price

$45.42

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-27

Symbol

bcba/AZND

Website

https://www.astrazeneca.com

Metric	Value
Average P/E ratio (10Y)	84.65x
Average P/E ratio (3Y)	30.99x
Average P/E ratio (5Y)	130.79x
Earnings yield	3.91%
EV/Earnings	29.04x
EV/EBIT	19.46x
EV/EBITDA	14.11x
EV/FCF	28.44x
EV/Sales	4.75x
FCF / EV yield	3.52%
FCF yield	3.88%
Forward P/E	15.78x
Graham number	17.9861
Graham upside	-60.4%
Lynch fair value	$39.03
Lynch upside	-14.07%
P/(FCF - SBC) ratio	26.67x
P/(OCF - SBC) ratio	20.61x
P/B ratio	5.45x
P/E ratio	25.57x
P/FCF ratio	25.76x
P/OCF ratio	20.06x
P/S ratio	4.48x
Price/EBITDA ratio	13.57x

Metric

Value

Average P/E ratio (10Y)

84.65x

Average P/E ratio (3Y)

30.99x

Average P/E ratio (5Y)

130.79x

Earnings yield

3.91%

EV/Earnings

29.04x

EV/EBIT

19.46x

EV/EBITDA

14.11x

EV/FCF

28.44x

EV/Sales

4.75x

FCF / EV yield

3.52%

FCF yield

3.88%

Forward P/E

15.78x

Graham number

17.9861

Graham upside

-60.4%

Lynch fair value

$39.03

Lynch upside

-14.07%

P/(FCF - SBC) ratio

26.67x

P/(OCF - SBC) ratio

20.61x

P/B ratio

5.45x

P/E ratio

25.57x

P/FCF ratio

25.76x

P/OCF ratio

20.06x

P/S ratio

4.48x

Price/EBITDA ratio

13.57x

Metric	Value
EBIT margin	24.42%
EBITDA margin	33%
Effective tax rate	16.95%
FCF margin	16.76%
Gross margin	81.69%
Operating margin	24.42%
Pretax margin	20.51%
Profit margin	17.02%
Profit per employee	$161M
Profitable quarters	18
Profitable years	36
Revenue per employee	$946M
ROA	8.21%
ROA (5Y)	5.95%
ROCE	17.78%
ROE	21.96%
ROE (5Y)	13.03%
ROIC	16.43%
ROIC (5Y)	13.29%
SBC / revenue	0.6%
Tax / revenue	3.48%

Metric

Value

EBIT margin

24.42%

EBITDA margin

33%

Effective tax rate

16.95%

FCF margin

16.76%

Gross margin

81.69%

Operating margin

24.42%

Pretax margin

20.51%

Profit margin

17.02%

Profit per employee

$161M

Profitable quarters

Profitable years

Revenue per employee

$946M

ROA

8.21%

ROA (5Y)

5.95%

ROCE

17.78%

ROE

21.96%

ROE (5Y)

13.03%

ROIC

16.43%

ROIC (5Y)

13.29%

SBC / revenue

0.6%

Tax / revenue

3.48%

Metric	Value
EPS growth	25.84%
EPS growth (Q)	2.55%
EPS growth (QoQ)	-18.27%
EPS growth 10Y	14.33%
EPS growth 3Y	19.13%
EPS growth 5Y	18.4%
EPS growth years	4
FCF growth	-4.55%
FCF growth (Q)	-22.92%
FCF growth (QoQ)	-25.25%
FCF growth 3Y	5.66%
FCF growth 5Y	14.81%
Gross profit growth	7.69%
Gross profit growth (Q)	7.25%
Gross profit growth 3Y	9.19%
Gross profit growth 5Y	17.24%
Net income growth	25.93%
Net income growth (Q)	2.33%
Net income growth (QoQ)	-18.6%
Net income growth 3Y	19.23%
Net income growth 5Y	22.6%
Net income growth years	4
OCF growth	2.32%
OCF growth (Q)	-15.39%
OCF growth (QoQ)	-14.71%
OCF growth 10Y	14.02%
OCF growth 3Y	10.41%
OCF growth 5Y	16.27%
Operating income growth	5.8%
Operating income growth (Q)	2.88%
Operating income growth 3Y	9.95%
Operating income growth 5Y	31.31%
Revenue growth	8.61%
Revenue growth (Q)	6.41%
Revenue growth (QoQ)	0.63%
Revenue growth 10Y	9.81%
Revenue growth 3Y	11.32%
Revenue growth 5Y	15.75%
Revenue growth quarters	13
Revenue growth years	7

Metric

Value

EPS growth

25.84%

EPS growth (Q)

2.55%

EPS growth (QoQ)

-18.27%

EPS growth 10Y

14.33%

EPS growth 3Y

19.13%

EPS growth 5Y

18.4%

EPS growth years

FCF growth

-4.55%

FCF growth (Q)

-22.92%

FCF growth (QoQ)

-25.25%

FCF growth 3Y

5.66%

FCF growth 5Y

14.81%

Gross profit growth

7.69%

Gross profit growth (Q)

7.25%

Gross profit growth 3Y

9.19%

Gross profit growth 5Y

17.24%

Net income growth

25.93%

Net income growth (Q)

2.33%

Net income growth (QoQ)

-18.6%

Net income growth 3Y

19.23%

Net income growth 5Y

22.6%

Net income growth years

OCF growth

2.32%

OCF growth (Q)

-15.39%

OCF growth (QoQ)

-14.71%

OCF growth 10Y

14.02%

OCF growth 3Y

10.41%

OCF growth 5Y

16.27%

Operating income growth

5.8%

Operating income growth (Q)

2.88%

Operating income growth 3Y

9.95%

Operating income growth 5Y

31.31%

Revenue growth

8.61%

Revenue growth (Q)

6.41%

Revenue growth (QoQ)

0.63%

Revenue growth 10Y

9.81%

Revenue growth 3Y

11.32%

Revenue growth 5Y

15.75%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-4.5T
Depreciation and amortization	$8.1T
EBIT	$22.2T
EBITDA	$30T
EPS	$2,728.76
Financing cash flow	$-11.4T
Free cash flow	$15.8T
Free cash flow minus SBC	$15.3T
Gross profit	$74.3T
Income taxes	$3.2T
Investing cash flow	$-12.1T
Net borrowing	$-2.9T
Net cash flow	$-3.2T
Net income	$15.5T
Operating cash flow minus SBC	$19.8T
Operating income	$22.2T
Revenue	$90.9T
Stock-based compensation	$542.2B

Metric

Value

Capital expenditures

$-4.5T

Depreciation and amortization

$8.1T

EBIT

$22.2T

EBITDA

$30T

EPS

$2,728.76

Financing cash flow

$-11.4T

Free cash flow

$15.8T

Free cash flow minus SBC

$15.3T

Gross profit

$74.3T

Income taxes

$3.2T

Investing cash flow

$-12.1T

Net borrowing

$-2.9T

Net cash flow

$-3.2T

Net income

$15.5T

Operating cash flow minus SBC

$19.8T

Operating income

$22.2T

Revenue

$90.9T

Stock-based compensation

$542.2B

Metric	Value
Altman Z-Score	3.58
Book value per share	$48,041.29
Debt / EBITDA	1.57
Debt / equity	0.64
Debt / FCF	3.03
Goodwill	$32.5T
Interest coverage	10.64
Long-term assets	$128.6T
Long-term liabilities	$48.5T
Net cash (debt)	$-40.6T
Net cash / market cap	-9.97%
Net debt / EBITDA	1.35
Net debt / equity	0.54
Net debt / FCF	2.57
Piotroski F-Score	7
Property, plant and equipment	$25T
Shareholders' equity	$74.6T
Tangible book value	$-12.8T
Tangible book value per share	$-8,223.23
Total assets	$171.6T
Total cash	$7.4T
Total debt	$47.9T
Total liabilities	$97T

Metric

Value

Altman Z-Score

3.58

Book value per share

$48,041.29

Debt / EBITDA

1.57

Debt / equity

0.64

Debt / FCF

3.03

Goodwill

$32.5T

Interest coverage

10.64

Long-term assets

$128.6T

Long-term liabilities

$48.5T

Net cash (debt)

$-40.6T

Net cash / market cap

-9.97%

Net debt / EBITDA

1.35

Net debt / equity

0.54

Net debt / FCF

2.57

Piotroski F-Score

Property, plant and equipment

$25T

Shareholders' equity

$74.6T

Tangible book value

$-12.8T

Tangible book value per share

$-8,223.23

Total assets

$171.6T

Total cash

$7.4T

Total debt

$47.9T

Total liabilities

$97T

Metric	Value
Asset turnover	0.54
Current assets	$43T
Current liabilities	$48.5T
Current ratio	0.89
Inventory turnover	1.68
Net working capital	$-3.3T
Quick ratio	0.66
Working capital	$-5.3T
Working capital turnover	-22,214.72

Metric

Value

Asset turnover

0.54

Current assets

$43T

Current liabilities

$48.5T

Current ratio

0.89

Inventory turnover

1.68

Net working capital

$-3.3T

Quick ratio

0.66

Working capital

$-5.3T

Working capital turnover

-22,214.72

Metric	Value
Buyback yield / dilution	0.03%
Dividend growth	5.21%
Dividend growth (3Y)	4.38%
Dividend growth years	3
Dividend payment date	2026-09-08
Dividend payment years	5
Dividend payout frequency	Semi-Annual
Dividend per share	$1,075.42
Dividend yield	1.54%
Ex-dividend date	2026-08-07
Last dividend	$0.24
Payout ratio	45.73%
Shareholder yield	1.57%

Metric

Value

Buyback yield / dilution

0.03%

Dividend growth

5.21%

Dividend growth (3Y)

4.38%

Dividend growth years

Dividend payment date

2026-09-08

Dividend payment years

Dividend payout frequency

Semi-Annual

Dividend per share

$1,075.42

Dividend yield

1.54%

Ex-dividend date

2026-08-07

Last dividend

$0.24

Payout ratio

45.73%

Shareholder yield

1.57%

Metric	Value
150-day SMA	$46.02
1D price change	-0.85%
1M price change	4.13%
1M total return	4.13%
1W price change	4.46%
1W total return	4.46%
1Y price change	9%
1Y return CAGR	10.77%
1Y total return	10.77%
20-day SMA	$43.11
200-day SMA	$45.21
3M price change	2.69%
3M total return	3.35%
3Y price change	27.94%
3Y return CAGR	10.51%
3Y total return	34.95%
50-day SMA	$42.81
50-day SMA vs 200-day SMA	50under200
52-week high	$53.80
52-week high date	2026-02-27
52-week low	$39.97
52-week low date	2026-08-03
5Y price change	51.4%
5Y return CAGR	10.34%
5Y total return	63.52%
6M price change	-7.34%
6M total return	-6.75%
All-time high	$53.80
All-time high date	2026-02-24
All-time low	$28.00
All-time low date	2021-08-11
Average true range (ATR)	$0.77
Average volume	53
Change from 52-week high	-15.58%
Change from 52-week low	13.64%
Change from all-time high	-15.58%
Change from all-time low	62.21%
Change from open	0%
Day's gap	-0.85%
Dollar volume	$182
High price	$45.42
Low price	$45.42
Monthly RSI	54.18
Open price	$45.42
Previous close	$45.81
Price vs 150-day SMA	-1.31%
Price vs 20-day SMA	5.36%
Price vs 200-day SMA	0.46%
Price vs 50-day SMA	6.09%
Relative volume	0.08
RSI	60.92
Sharpe ratio	0.8
Sortino ratio	1.36
Volume	4
Weekly RSI	53.36
YTD price change	-9.16%
YTD total return	-7.69%

Metric

Value

150-day SMA

$46.02

1D price change

-0.85%

1M price change

4.13%

1M total return

4.13%

1W price change

4.46%

1W total return

4.46%

1Y price change

1Y return CAGR

10.77%

1Y total return

10.77%

20-day SMA

$43.11

200-day SMA

$45.21

3M price change

2.69%

3M total return

3.35%

3Y price change

27.94%

3Y return CAGR

10.51%

3Y total return

34.95%

50-day SMA

$42.81

50-day SMA vs 200-day SMA

50under200

52-week high

$53.80

52-week high date

2026-02-27

52-week low

$39.97

52-week low date

2026-08-03

5Y price change

51.4%

5Y return CAGR

10.34%

5Y total return

63.52%

6M price change

-7.34%

6M total return

-6.75%

All-time high

$53.80

All-time high date

2026-02-24

All-time low

$28.00

All-time low date

2021-08-11

Average true range (ATR)

$0.77

Average volume

Change from 52-week high

-15.58%

Change from 52-week low

13.64%

Change from all-time high

-15.58%

Change from all-time low

62.21%

Change from open

Day's gap

-0.85%

Dollar volume

$182

High price

$45.42

Low price

$45.42

Monthly RSI

54.18

Open price

$45.42

Previous close

$45.81

Price vs 150-day SMA

-1.31%

Price vs 20-day SMA

5.36%

Price vs 200-day SMA

0.46%

Price vs 50-day SMA

6.09%

Relative volume

0.08

RSI

60.92

Sharpe ratio

0.8

Sortino ratio

1.36

Volume

Weekly RSI

53.36

YTD price change

-9.16%

YTD total return

-7.69%

Metric	Value
Float	1.5B
Shares change (QoQ)	-0.06%
Shares change (YoY)	-0.03%
Shares held by insiders	0.04%
Shares held by institutions	74.28%

Metric

Value

Float

1.5B

Shares change (QoQ)

-0.06%

Shares change (YoY)

-0.03%

Shares held by insiders

0.04%

Shares held by institutions

74.28%

BCBA/AZND (BCBA/AZND)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/AZND

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/AZND indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/AZND

Frequently asked questions